Based on the data gathered from our in vitro and in vivo experiments so far, we assumed that PTX3 opsonizes small CaOx crystals and thereby inhibits further crystal growth and aggregation, which would result in vivo in crystal plug formation, kidney injury and progressive CKD. Here, PTX3 is linked to chronic kidney disease.